PF-Atlas › Clinical Trials › NCT00013702

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Adefovir · Phase 2

Registry ID

NCT00013702

Phase

Phase 2

Status

Completed

Drug / intervention

Adefovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Start

2001-03

About this trial

Adefovir is evaluated in NCT00013702, a Phase 2 idiopathic pulmonary fibrosis study sponsored by National Institute of Allergy and Infectious Diseases (NIAID). Current status: Completed.

View NCT00013702 on ClinicalTrials.gov →

Explore related

All Adefovir trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00013702 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.